Last reviewed · How we verify
Peflutren Lipid Microsphere Injectable Suspension — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Peflutren Lipid Microsphere Injectable Suspension (Peflutren Lipid Microsphere Injectable Suspension) — Lantheus Medical Imaging.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Peflutren Lipid Microsphere Injectable Suspension TARGET | Peflutren Lipid Microsphere Injectable Suspension | Lantheus Medical Imaging | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Peflutren Lipid Microsphere Injectable Suspension CI watch — RSS
- Peflutren Lipid Microsphere Injectable Suspension CI watch — Atom
- Peflutren Lipid Microsphere Injectable Suspension CI watch — JSON
- Peflutren Lipid Microsphere Injectable Suspension alone — RSS
Cite this brief
Drug Landscape (2026). Peflutren Lipid Microsphere Injectable Suspension — Competitive Intelligence Brief. https://druglandscape.com/ci/peflutren-lipid-microsphere-injectable-suspension. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab